These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17194592)

  • 1. Secreted bacterial phospholipase A2 enzymes: better living through phospholipolysis.
    Sitkiewicz I; Stockbauer KE; Musser JM
    Trends Microbiol; 2007 Feb; 15(2):63-9. PubMed ID: 17194592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ExoU is a potent intracellular phospholipase.
    Sato H; Frank DW
    Mol Microbiol; 2004 Sep; 53(5):1279-90. PubMed ID: 15387809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial phospholipases and their role in virulence.
    Songer JG
    Trends Microbiol; 1997 Apr; 5(4):156-61. PubMed ID: 9141190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudolipasin A is a specific inhibitor for phospholipase A2 activity of Pseudomonas aeruginosa cytotoxin ExoU.
    Lee VT; Pukatzki S; Sato H; Kikawada E; Kazimirova AA; Huang J; Li X; Arm JP; Frank DW; Lory S
    Infect Immun; 2007 Mar; 75(3):1089-98. PubMed ID: 17178785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo phospholipase activity of the Pseudomonas aeruginosa cytotoxin ExoU and protection of mammalian cells with phospholipase A2 inhibitors.
    Phillips RM; Six DA; Dennis EA; Ghosh P
    J Biol Chem; 2003 Oct; 278(42):41326-32. PubMed ID: 12915403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and Verification of Ubiquitin-Activated Bacterial Phospholipases.
    Tessmer MH; Anderson DM; Pickrum AM; Riegert MO; Frank DW
    J Bacteriol; 2019 Feb; 201(4):. PubMed ID: 30455285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eicosanoid-mediated proinflammatory activity of Pseudomonas aeruginosa ExoU.
    Saliba AM; Nascimento DO; Silva MC; Assis MC; Gayer CR; Raymond B; Coelho MG; Marques EA; Touqui L; Albano RM; Lopes UG; Paiva DD; Bozza PT; Plotkowski MC
    Cell Microbiol; 2005 Dec; 7(12):1811-22. PubMed ID: 16309466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the major ubiquitin-binding domain of the Pseudomonas aeruginosa ExoU A2 phospholipase.
    Anderson DM; Feix JB; Monroe AL; Peterson FC; Volkman BF; Haas AL; Frank DW
    J Biol Chem; 2013 Sep; 288(37):26741-52. PubMed ID: 23908356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of superoxide dismutase as a cofactor for the pseudomonas type III toxin, ExoU.
    Sato H; Feix JB; Frank DW
    Biochemistry; 2006 Aug; 45(34):10368-75. PubMed ID: 16922513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of phospholipase activity of the Pseudomonas aeruginosa type III cytotoxin, ExoU.
    Sato H; Feix JB; Hillard CJ; Frank DW
    J Bacteriol; 2005 Feb; 187(3):1192-5. PubMed ID: 15659695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The human pathogen Pseudomonas aeruginosa utilizes conserved virulence pathways to infect the social amoeba Dictyostelium discoideum.
    Pukatzki S; Kessin RH; Mekalanos JJ
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):3159-64. PubMed ID: 11867744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperative Substrate-Cofactor Interactions and Membrane Localization of the Bacterial Phospholipase A
    Tessmer MH; Anderson DM; Buchaklian A; Frank DW; Feix JB
    J Biol Chem; 2017 Feb; 292(8):3411-3419. PubMed ID: 28069812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eukaryotic localization, activation and ubiquitinylation of a bacterial type III secreted toxin.
    Stirling FR; Cuzick A; Kelly SM; Oxley D; Evans TJ
    Cell Microbiol; 2006 Aug; 8(8):1294-309. PubMed ID: 16882033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Pseudomonas aeruginosa type III effectors in disease.
    Engel J; Balachandran P
    Curr Opin Microbiol; 2009 Feb; 12(1):61-6. PubMed ID: 19168385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudomonas aeruginosa Type III Secretory Toxin ExoU and Its Predicted Homologs.
    Sawa T; Hamaoka S; Kinoshita M; Kainuma A; Naito Y; Akiyama K; Kato H
    Toxins (Basel); 2016 Oct; 8(11):. PubMed ID: 27792159
    [No Abstract]   [Full Text] [Related]  

  • 16. Subcellular alterations that lead to diarrhea during bacterial pathogenesis.
    Guttman JA; Finlay BB
    Trends Microbiol; 2008 Nov; 16(11):535-42. PubMed ID: 18819802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ExoU-induced procoagulant activity in Pseudomonas aeruginosa-infected airway cells.
    Plotkowski MC; Feliciano LF; Machado GB; Cunha LG; Freitas C; Saliba AM; de Assis MC
    Eur Respir J; 2008 Dec; 32(6):1591-8. PubMed ID: 18684846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational Changes and Membrane Interaction of the Bacterial Phospholipase, ExoU: Characterization by Site-Directed Spin Labeling.
    Feix JB; Kohn S; Tessmer MH; Anderson DM; Frank DW
    Cell Biochem Biophys; 2019 Mar; 77(1):79-87. PubMed ID: 30047043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial phospholipases.
    Titball RW
    Symp Ser Soc Appl Microbiol; 1998; 27():127S-137S. PubMed ID: 9750370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysophospholipase A activity of Pseudomonas aeruginosa type III secretory toxin ExoU.
    Tamura M; Ajayi T; Allmond LR; Moriyama K; Wiener-Kronish JP; Sawa T
    Biochem Biophys Res Commun; 2004 Apr; 316(2):323-31. PubMed ID: 15020221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.